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Abstract 
Background: Individuals with dementia with Lewy Bodies (DLB) exhibit motor impairments 
similar to those seen in Parkinson’s disease (PD), including gait disturbances, thus increasing 
their risk for falls. While research suggests that treadmill training is a successful treatment 
modality in PD, our current study is the first to investigate its effects in the DLB population. The 
purpose of this study was to investigate the safety, feasibility, and effects on gait of a single 20 
minute session of treadmill walking (TW) in individuals with DLB. We hypothesized that TW 
would improve gait velocity, and spatial and temporal gait parameters. Methods: This study 
utilized a one group pre-test/post-test design with ANOVA analysis. Eight individuals with a 
diagnosis of DLB underwent the 20 minute TW intervention. Spatiotemporal gait parameters in 
forward, forward fast, and backward walking were assessed with GAITRite before and after the 
intervention. Results: No abnormal HR or BP responses were observed during the intervention 
or testing. No adverse events occurred. Seven of eight (87.5%) participants were able to 
complete the TW and testing; 4 participants achieved their comfortable overground walking 
speed on the treadmill. There were significant improvements in temporal gait measures of 
comfortable walking post-TW. For example, we found an increase in stride velocity (71.22 ± 
19.45 cm/s to 79.68 ± 23.43 cm/s; P = 0.028), a decrease in stance time (0.83 ± 0.04 s to 0.78 
±0.04 s; P = 0.006), and a decrease in double support time (0.47 ±0.05 to 0.43 ± 0.06; P = 0.012) 
post-intervention. There were no significant changes in spatiotemporal measures of backwards 
and fast walking gait parameters. Conclusions: This study demonstrates that TW is safe and 
feasible in individuals with DLB. All subjects improved on velocity and the majority of temporal 
parameters of gait exclusively in comfortable walking, suggesting that the benefits of TW may 
be task specific. Pace training on a treadmill with multiple sessions may be a beneficial 
intervention for individuals with DLB. 
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Background 
Dementia is a general term for a decline in mental ability that is severe enough to 
interfere with an individual’s daily life. Dementia is not a single disease; rather it encompasses a 
wide range of symptoms associated with impairments in mental function such as losses in 
memory, communication and language, ability to focus, reasoning and judgment, and visual 
perception. Alzheimer’s disease (AD) is the most common form of dementia, accounting for 60 
to 80 percent of all cases. Other forms of dementia include vascular dementia, dementia with 
Lewy Bodies, Huntington’s disease, Parkinson’s disease (PD) dementia, Creutzfeldt-Jakob 
disease, normal pressure hydrocephalus, Wernicke-Korsakoff Syndrome, frontotemporal 
dementia, and mixed dementia. Although these dementias are associated with different 
mechanisms of brain cell damage, they have many overlapping symptoms making it difficult for 
doctors to differentiate their diagnoses. While some symptoms of dementia can be reversed by 
correcting the cause of the problems, most dementias are progressive neurodegenerative diseases 
with no cure and no treatments to slow or stop progression. Treatment is instead focused on 
temporarily relieving symptoms so that the affected individual can function to their greatest 
ability.
1 
Dementia with Lewy Bodies, hereafter referred to as DLB, is the third most common 
subtype of dementia accounting for 10 to 25 percent of all cases, and is characterized by the 
presence of protein deposits in the brain.
1
 DLB is a progressive neurological disease and will 
lead to deteriorating motor function, severe memory disturbance, neuroleptic reactions, 
disproportionate visuospatial deficits, and global functioning deterioration in late stages.
2,3
 The 
protein deposits in DLB, termed Lewy bodies after their discovery by Frederick Lewy in the 
early 1900s, are composed of  alpha-synuclein protein and  have been found to deplete 
  
5 
cholinergic and dopaminergic markers in varying areas of the brain.
2
 Lewy bodies are also found 
in other types of dementia, most commonly PD dementia and AD, suggesting that these 3 
diseases may be related to the same underlying abnormalities in how the brain processes alpha-
synuclein.
4
 Although causes of these processing abnormalities are not known, a case-control 
study of individuals with DLB has shown that a history of anxiety, depression, stroke, and a 
family history of PD are risk factors for the development of DLB, and that those with DLB are 
significantly less likely to have had cancer or use caffeine compared to controls.
5
 DLB typically 
presents between the ages of 50 and 85 with the mean age of onset at 68 years.
3
 DLB is 
associated with a greater risk of mortality and institutionalization than AD.
3,6
   
DLB presents with many non-specific, cognitive, and motor manifestations. A majority 
of DLB patients will experience fluctuations in cognition that resemble signs of delirium. These 
fluctuations include excessive daytime sleepiness and transient confusion, and varying levels of 
attention and alertness that can last over minutes, hours, or days. Other non-specific 
manifestations include syncope, delusions, transient loss of consciousness, multimodal 
hallucinations, and visual hallucinations in 13-80% of all patients. Cognitive manifestations  of 
DLB include severe memory impairment, attentional deficits, visuospatial dysfunction, difficulty 
with recognizing faces (prosopagnosia) and colors (color agnosia), and problems with 
assembling/drawing objects (constructional apraxia) and initiating hand movements (ideomotor 
apraxia). Language skills are negatively impacted by spoken false memories (confabulation), 
incoherence, involuntary repetition (perseveration), difficulty naming common objects, and a 
reduction in verbal fluency. Changes in brain and cardiovascular structures are also present in 
DLB and can help distinguish this disease from other dementias.
3
 The rate of cognitive decline in 
DLB is similar to that seen in AD, but with less memory loss in the early stages than AD.
2,3
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Motor manifestations include akinetic-rigid syndrome, tremor, slowness of movement 
(bradykinesia), and postural instability.
3 
DLB, PD, and PD dementia share many common symptoms, therefore it is pertinent to 
note these as well as their differences. Non-motor symptoms that are common in both DLB and 
PD dementia are depression, visual hallucination, delusion, trouble interpreting visual 
information, malfunctions of the autonomic nervous system, and a condition known as rapid eye 
movement sleep behavior disorder in which the individual physically acts out while dreaming.
4
 
Movement impairments in individuals with DLB are very similar to those seen in PD. 
Overlapping motor manifestations between the two diseases include hunched posture, balance 
problems, falls, rigid muscles, shuffling walk, trouble initiating movement, bradykinesia, and 
facial masking.
2,4
 Unlike PD, motor symptoms of DLB are usually bilateral instead of unilateral 
and no rest tremor is present. The onset and severity of parkinsonian symptoms in DLB are 
highly variable.
2 
It may be difficult to clinically diagnose DLB as this disease shares many features with 
other dementias. Definitive diagnosis of DLB is made only after a brain autopsy upon death.
2
 
The first consensus guidelines for the clinical diagnosis of DLB were made in 1996 and revised 
in 2005, but the accuracy of clinical diagnosis has still been relatively low.
2,3,7
 Because of these 
accuracy issues, more than 50% of DLB cases are missed, possibly leading to ineffective 
treatment strategies and severe adverse effects of treatment.
8
 DLB diagnosis is made when 2 of 
the following 3 core diagnostic features are present in addition to dementia; 1.) fluctuating 
cognition, 2.) visual hallucinations, and 3.) movement disorder. The presence of suggestive 
features such as REM sleep behavior disorder, severe neuroleptic sensitivity, and low dopamine 
transporter uptake can also aid in diagnosis. Similar to the diagnostic procedures for other 
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dementias, history taking, physical and mental examinations, and lab tests are used in the 
diagnosis of DLB.
3
 Because DLB, PD dementia, and AD present with similar symptoms, the 
timing of symptom onset is key in diagnosing the correct disorder. The main difference between 
DLB and PD dementia is the presence of movement symptoms before dementia symptoms. The 
diagnosis of DLB is made when dementia symptoms associated with DLB develop first, when 
both dementia symptoms and movement symptoms are present at the time of diagnosis, or when 
movement symptoms present within a year after DLB diagnosis. On the other hand, if only 
movement symptoms are present at the time of original PD diagnosis and dementia symptoms 
appear a year or more later, then the diagnosis is PD dementia.
4
 DLB is most commonly 
misdiagnosed as AD, but is increasingly differentiated from AD through the use of biomarkers 
tests, such as those that measure alpha synuclein and oxidized alpha-helical form of amyloid β40 
in the cerebrospinal fluid.
3,4
   
There are currently no treatments that can stop or slow the progression of brain cell 
damage in DLB. Rather, treatments are focused on relieving symptoms of DLB to improve 
quality of life for affected individuals.
4
 Pharmacologic management may include the use of 
cholinesterase inhibitors, psychostimulants, atypical neuroleptics, and selective serotonin 
reuptake inhibitors.
9
 Cholinesterase inhibitors work to improve the cholinergic deficit seen in 
DLB and aim to treat cognitive symptoms and improve consciousness. Rivastigmine is the most 
commonly used cholinesterase inhibitor, with one study showing significant improvement in 
50% of patients.
3
 Psychostimulants, such as levodopa, are used to improve extrapyramidal signs 
and motor symptoms.
3
 Levodopa has shown to be tolerable and beneficial in managing motor 
symptoms in small trials of DLB patients, but has not been shown to be as effective in DLB as it 
has in individuals with PD and PD dementia.
2,3
 Atypical neuroleptics may help relieve symptoms 
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of delusions and agitation but their use should be closely monitored.
9,10
 Finally, selective 
serotonin uptake inhibitors can be used to treat symptoms of depression and anxiety.
9
   
For the purpose of this study, we chose to focus our efforts on the management of motor 
manifestations of DLB, specifically disorders of gait. Gait is defined by the Merriam-Webster 
dictionary as a manner of walking or moving on foot.
11
 Gait impairments in individuals with 
DLB include decreased velocity, shorter step lengths, decreased arm swing, stooped posture, and 
shuffling gait.
12
 Gait and balance disorders have been shown to be prevalent in 40 percent of 
individuals with mild dementia, 87 percent with moderate dementia, and 100 percent with severe 
dementia.
12
 This is a cause for concern since disorders of gait are one of the major determinants 
of a patient’s independence and quality of life.13 Additionally, these gait impairments lead to an 
increased risk of falls as demonstrated by the finding that 37 percent of patients with DLB 
experienced multiple falls (> 5) over a 3 month period.
14
 In another study, 77% of the DLB 
subjects (N = 30) experienced at least one fall over the course of a year.
15
  
Based on reports that up to 70 percent of DLB patients have parkinsonian symptoms, 
including gait impairments, we reason that the DLB population may benefit from treatments 
typically utilized in the PD population.
12
 One relatively new mode of therapy that has been 
implemented in the treatment of PD is treadmill training.
16
 In this form of therapy, an individual 
is subjected to a single session or multiple sessions of walking on a treadmill. The results from 
post-treadmill overground walking tests are then compared to the subject’s pre-treadmill test 
results to examine changes in various gait parameters.  
There have been several studies that have investigated the effects of a treadmill walking 
(TW) intervention on gait parameters in individuals with PD. These studies have shown that 
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treadmill training may have the ability to reduce gait disturbances in those affected by PD, 
suggesting that this may be used as a complementary or alternative option to traditional 
therapy.
13,17-20
 While most of these studies have implemented interventions consisting of multiple 
walking sessions over an extended period of time, three studies have investigated the immediate 
effects of a single session of treadmill training for individuals with PD. To better examine the 
effects of our intervention in relation to the current research, we will be focusing on the three 
studies that utilized a single session of TW to improve gait parameters. These studies are 
discussed in more detail below. In all three studies, the participants wore an overhead safety 
harness while on the treadmill to protect against falls. No adverse events were reported as a 
result of treadmill training.
13,19,20
 
In a study by Pohl et al., seventeen individuals with early PD (Hoehn and Yahr scale 
stages I through III; i.e. motor symptoms ranging from mild to moderately severe
21
) and gait 
disturbances participated in 3 gait training interventions and one control intervention. One 
intervention was given per day for 4 consecutive days. The interventions had varying 
methodologies: 1.) structured speed-dependent treadmill training (STT), 2.) limited progressive 
treadmill training (LTT), 3.) conventional gait therapy (CGT), and 4.) a control intervention. In 
the STT intervention, participants walked on a treadmill for a total of 30 minutes with at least 5 
incremental 10% increases in training speed depending on the participant’s ability to walk safely. 
For the LTT intervention, participants walked at their pre-tested overground walking speed for 
30 minutes with no increases in training speed. Brief rests were given in both STT and LTT 
interventions as needed. The CGT intervention consisted of physiotherapeutic gait therapy for 30 
minutes administered by two skilled therapists trained in gait therapy (i.e. proprioceptive 
neuromuscular fascicultation (PNF)) techniques. For the control intervention, participants did not 
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receive any therapeutic treatment and instead rested in a recumbent or comfortable sitting 
position for 30 minutes. The results of the interventions showed no significant changes in any 
gait parameters after CGT and the control intervention. There were significant improvements in 
speed, stride length, and double-stance duration after STT and LTT interventions, and a 
significant gain in de-loading rate after STT with no significant changes in symmetry parameters 
or other vertical forces across all interventions.
19 
Frenkel-Toledo et al. conducted a study comparing gait measures across three walking 
conditions: usual walking, walking with the assistance of a wheeled walker, and walking on a 
treadmill. Thirty-six individuals with early stage PD and 30 control subjects participated. 
Participants were required to perform each intervention for two minutes; treadmill speed was set 
to their walker-assisted gait speed. Gait parameter measures in the treadmill intervention were 
compared to measures of the walker-assisted intervention. The treadmill was shown to 
significantly reduce stride time variability and swing time variability in both PD and control 
subjects, significantly reduce the swing time of PD subjects but not controls, and significantly 
reduce the fractal index (i.e., indicating a less ordered, more random stride time series) of the 
controls but not the PD subjects. No significant treadmill effect was found on stride length or 
average stride time, due to the same gait speeds between the two interventions. These results 
indicate that a treadmill acts as an external pacemaker to significantly reduce gait variability and 
enhance gait stability.
20 
In a study conducted by Bello et al., 16 individuals with PD (8 moderate PD and 8 
advanced PD participants as determined by the Hoehn and Yahr scale) and 8 healthy controls 
participated in a TW session. The treadmill intervention consisted of five 4 minute blocks of TW 
with 3 minute rest periods in between blocks. The target speed of the treadmill belt was the 
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participant’s pre-intervention overground walking speed. All participants were able to reach their 
target speed by the 5
th
 4-minute block, thus measurements from this block were used to compare 
pre- and post-intervention measurements. Post-intervention measurements were taken 
immediately after the intervention as well as 5 and 10 minutes after. For all participants, the three 
post-treadmill measurements of gait speed and step length were significantly higher than pre-
intervention values. There was a significant increase in gait cadence in the immediate post-
intervention measurement of the control and moderate PD groups when compared to their pre-
intervention cadence. Cadence remained significantly high for the control and advanced PD 
groups in the second and third post-intervention tests. These results suggest that a single session 
of treadmill training improves overground gait and the effects last for at least 15 minutes.
13 
Based on the positive results of a single session of treadmill training seen in individuals 
with PD and the similarities in movement and gait disturbances between PD and DLB, we chose 
to investigate the effects of providing a TW intervention to individuals with DLB. To our 
knowledge, no studies to date have assessed the effects of TW to improve gait parameters in 
individuals with DLB. The primary purpose of this study was to investigate the safety, 
feasibility, and possible effects on gait in individuals with DLB. We hypothesized that a single 
20 minute session of TW would improve gait velocity, and spatial and temporal gait parameters 
in individuals diagnosed with DLB. 
 
 
Methods 
Population and Sample 
 Eight individuals with a diagnosis of DLB were recruited from the Movement Disorders 
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Clinic and the Memory Disorders Clinic at The Ohio State University Wexner Medical Center to 
participate in the study. These individuals met the inclusion criteria of being able to walk 80 feet 
without assistance, to provide informed consent and assent, and to understand directions. 
Participants were required to have their Legally Authorized Representative (LAR) sign the 
consent form and the participant gave assent. Individuals were excluded from the study if they 
had any clinically significant musculoskeletal or neurological disease, other than DLB, that 
would affect gait. Institutional Review Board approval was obtained. 
Study Design 
 
 The investigation utilized a one group pre-test/post-test design with control for learning 
effects within subjects to compare changes in gait parameters. Data was collected in the form of 
two pre-test measures and one post-test measure. Measurements were taken using the GAITRite 
system (an electronic sensitized carpet) and the Timed “Up and Go” (TUG) Test which are 
discussed in more detail below.  
Outcome Measures 
 
Spatiotemporal gait parameters were measured using the GAITRite system. This system 
consists of a 4.88 meter electronic carpet with sensors that record footfalls to a computer 
software program. The GAITRite system has been shown to have a strong concurrent validity 
with a more commonly used system, the Clinical Stride Analyzer, for the measurement of 
footfall patterns in adults and has been found to have a high test-retest reliability in both healthy 
adults and those suffering from a neurological disorder.
22,23 
The TUG Test was used to measure mobility and fall risk. This test requires participants 
to stand up from a chair, walk 3 meters, turn around and return to the chair.
24
 It has been found 
that adults with PD who took more than 11.5 seconds to complete the TUG test were at a risk for 
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falls (sensitivity = 0.66, specificity = 0.62).
25
 The TUG test has been shown to be a reliable and 
valid measure for quantifying functional mobility.
24
  
Procedures 
 Participants began pre-test 1 by walking on the GAITRite carpet to complete 4 trials each of 
forward walking at a comfortable speed, forward walking at a fast speed, and backward walking 
at a comfortable speed for a total of 12 trials. They then completed TUG testing to obtain 
outcome measures for pre-test 1. After pre-test 1, participants sat in a chair and rested for 20 
minutes before being retested on all measures (pre-test 2) to control for learning effects. 
Participants were then placed in a harness over the treadmill that acted solely as a safety measure 
and did not support their weight. After familiarization with the treadmill, participants completed 
a total of 20 minutes of TW. The treadmill protocol aimed to set the treadmill speed to each 
participant’s comfortable overground walking speed, as determined by GAITRite data, for the 
first five minutes provided that they could walk at this speed safely (i.e. no abnormal vital signs, 
excessive effort, or loss of balance). Speed would then be incrementally increased by 10% at 
each 5 minute period (3 times total) thereafter. If the participant could not walk safely after a 
speed increase, the speed was decreased to their previous comfortable speed and maintained at 
that level for the remainder of the training session. Participants were asked to report their Rated 
Perceived Exertion (RPE) on a 0 – 10 scale, where 0 indicates no effort at all and 10 indicates 
maximum effort, at each five minute interval. Rest breaks were given as needed during the TW 
intervention, with the participants returning to their last comfortable speed after resting. 
Immediately after the completion of the 20 minute treadmill session, participants were retested 
on all outcome measures (post-test).  
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Data Analysis 
Statistical analysis was completed using SPSS Version 22. Results from the GAITRite 
testing were analyzed using the average of three trials of each walking condition (comfortable 
speed, fast speed, backward walking) to assess differences in gait measures in all three 
conditions. Data from the GAITRite and TUG testing was analyzed using an Analysis of 
Variance (ANOVA) to discern any significant changes in the outcome measures of gait 
parameters after the treadmill training.  
Facilities and Resources 
 
Research was conducted in the Mobility and Exercise in Neurological Disorders (MEND) 
laboratory. The laboratory is located at The Ohio State University main campus in Atwell Hall, 
room 236. Equipment used, other than the measurement tools discussed previously, included the 
Biodex Gait Trainer 3 treadmill (950 model with extended handrails) and the Biodex Medical 
unweighing system. Aside from our patient recruitment from the OSU Movement Disorders 
Clinic or the OSU Memory Disorders Clinic, no other departments or outside agencies 
cooperated with the research project. 
 
 
Results 
Participant Characteristics 
Participant characteristics are presented in Table 1. Values are displayed as mean ± 
standard deviation. The study population consisted of eight individuals, 4 males and 4 females, 
with a mean age of 75.88 ± 6.36 years (range = 68 – 86). Years since diagnosis ranged from 0.17 
to 10 years (3.17 ± 3.35) while years since onset of symptoms ranged from 2 to 10 years (5.43 ± 
2.57). One participant reported experiencing two falls within the past week, two participants 
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reported at least one fall in the past 6 weeks, and three reported at least one fall in the past 6 
months. Two participants occasionally used a cane as an assistive device and one participant 
used a two-wheeled walker. Mean Mini-Mental State Examination (MMSE) scores for our study 
population (19.14 ± 9.14) indicated a positive screen for dementia (scores ≤ 24).26  
Intervention 
Seven of eight participants (87.5%) were able to complete the 20 minute TW intervention 
and subsequent testing. The participant who could not complete the intervention was only able to 
walk for 6 minutes and reported being “too tired” to perform post-intervention assessments. This 
participant also reported the longest time since symptom onset (10 years). Participants’ 
comfortable overground walking speeds were recorded using GAITRite. One participant’s 
overground walking speed was not obtained due to equipment malfunction. Although no 
participants were able to begin TW at their comfortable overground walking speed, four 
participants were able to attain their comfortable overground walking speed during the 20 
minutes on the treadmill. Additionally, three participants were able to follow the intervention 
protocol of 10% increases in speed at each 5 minute interval (Table 2). Participants were 
permitted to take as many rest breaks as needed throughout the 20 minutes of TW. Aside from 
the one participant who stopped after 6 minutes, one participant reported being very tired and 
took a total of four rest breaks for 5 minutes each and another participant took two breaks for a 
total time of 16 minutes. One participant needed constant cueing to walk with big steps and 
another reported that she had to think about stepping. 
The four participants who were able to attain their comfortable overground walking speed 
on the treadmill had higher MMSE scores (i.e., less cognitive impairment) than those who did 
not (Figure 1). After running a Spearman’s correlation we found that the ability to reach 
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comfortable walking speed on the treadmill during this 20 minute session had a strong positive 
correlation to MMSE scores (RS = 0.874; P = 0.01). 
Heart rate and blood pressure values were both taken prior to the TW intervention and 
after the intervention. Heart rate values were also taken at each 5 minute interval on the 
treadmill. Maximum heart rate values were calculated according to the Haskell and Fox (220 
minus age) equation. No participant reached their maximum heart rate and blood pressure 
responses were normal per ACSM guidelines (Table 3; Table 4).
27 
Participants were asked to rate their perceived exertion (RPE) during the intervention. 
Mean reported RPE values on a 0 – 10 scale indicated low perceived exertion. The highest 
reported RPE value was a 7 in the 15 – 20 minute interval of TW (Figure 2). 
Gait Parameters 
Measurements of gait parameters were obtained using the GAITRite system and TUG 
testing. Operational definitions of gait parameters and a diagram of the gait cycle are included in 
appendices B and C for reference. There were no significant differences in gait measures from 
pre-test 1 to pre-test 2, ruling out a learning effect of the testing. Therefore only the data 
comparing  pre-test 1 to post-test measures are reported, as the pre-test 1 values were thought to  
better represent the participants’ natural gait patterns at pretesting.  
GAITRite data showed significant differences in gait parameters from pre-intervention to 
post-intervention (Table 4). All significant changes were seen in comfortable walking. 
Additionally, all of these differences were in velocity and temporal measures of gait. 
Specifically, participants showed statistically significant increases in gait velocity, cadence, and 
stride velocity and decreases in stance time and double support time (P < 0.05). Step time was 
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approaching significance while there were no significant differences in swing time or spatial 
parameters of comfortable forward walking. Gait parameters of fast and backward walking did 
not change after a one-time 20 minute TW session. No subjects had markedly worse outcomes 
across gait measures after the TW intervention.  
Mean TUG scores improved post-intervention (25.78 ± 12.47 s and 18.87 ± 13.57 s, 
respectively), but this difference was not significant (P = 0.282). 
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Table 1. Participant characteristics 
 Mean ± SD (Range) 
Age (years) 75.88 ± 6.36 (68 – 86) 
Gender 
4 Male 
4 Female 
Years Post Diagnosis (N = 7) 3.17 ± 3.35 (0.17 – 10) 
Years since onset of symptoms 5.43 ± 2.57 (2 – 10) 
MMSE scores (N = 7) 19.14 ± 9.14 (0 – 27) 
MMSE = Mini-mental state examination 
 
 
 
 
Table 2. Treadmill speed 
Participant 
Comfortable 
Walking 
speed (mph) 
Speed (mph)  
0-5 mins 
Speed (mph)  
5-10 mins 
Speed (mph) 
10-15 mins 
Speed (mph) 
15-20 mins 
1 1.68 1.4 1.5 1.6 1.7 
2 1.07 0.3 NR NR NR 
3 1.01 0.2 0.4 0.4 0.3 
4 1.3 1.0 1.0 1.0 1.0 
5 1.28 1.0 1.1 1.2 1.3 
6 1.92 1.1 1.2 1.4 1.5 
7 1.76 1.4 1.4 1.5 1.8 
8 NR 1.7 1.8 1.9 2.0 
mph = miles per hour; mins = minutes; NR = not recorded 
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Table 3. Heart Rate values 
Participant 
Calculated 
HR Max 
Initial HR 
HR 
(0-5 min) 
HR 
(5-10 min) 
HR 
(10-15 min) 
HR 
(15-20 min) 
HR 
(Post-test) 
1 151 56 70 75 76 75 81 
2 144 60 NR NR NR NR NR 
3 145 97 80 85 79 85 85 
4 138 64 68 78 80 82 74 
5 134 54 53 63 84 80 100 
6 141 64 85 97 91 95 80 
7 149 80 100 105 109 112 100 
8 152 80 88 82 92 98 80 
HR = heart rate; HR max = maximum heart rate; NR = not recorded 
 
 
 
 
 
Table 4. Blood pressure values 
Participant Initial BP 
BP 
(Post-test) 
1 110/78 
 
120/82 
 2 100/64 NR 
3 108/60 118/80 
4 128/52 128/64 
5 100/60 110/67 
6 130/80 142/76 
7 135/78 118/80 
8 160/98 158/96 
BP = blood pressure; NR = not recorded 
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Table 5. GAITRite 
Gait Parameters 
(N=6) 
Pre-test 
Mean ± SD 
Post-test 
Mean ± SD 
Significance 
P-value 
Temporal measures 
Velocity (m/s) 0.70 ± 0.19 0.79 ± 0.23 P = 0.035 
Cadence 
(steps/minute) 
99.05 ± 5.62 104.67 ± 4.67 P = 0.033 
Step Time (s) 0.62 ± 0.03 0.58 ± 0.02 P = 0.055 
Stance Time (s) 0.83 ± 0.04 0.78 ± 0.04 P = 0.006 
Stride Velocity (cm/s) 71.22 ± 19.45 79.68 ± 23.43 P = 0.028 
Double Support Time 
(s) 
0.47  ± 0.05 0.43 ± 0.06 P = 0.012 
Swing Time (s) 0.38 ± 0.03 0.36 ± 0.04 P = 0.246 
Spatial measures 
Stride Length (cm) 85.66 ± 22.55 91.24 ± 27.22 P = 0.115 
Step Length (cm) 42.52 ± 11.37 46.09 ± 14.35 P = 0.145 
Swing Percentage 
Average (%) 
30.68 ± 2.22 31.34 ± 2.74 P = 0.267 
Double Support 
Percentage Average 
(%) 
38.59 ± 4.78 37.16 ± 5.62 P = 0.238 
HH Average (cm) 11.69 ± 4.75 10.91 ± 5.22 P = 0.118 
m/s = meters per second; cm/s = centimeters per second; HH: Heel-to-heel 
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 Achieved comfortable speed 
 Did not achieve comfortable speed 
 
Figure 1. Correlation between Mini-mental state examination (MMSE) score and treadmill 
speed 
The ability to achieve comfortable overground walking speeds on the treadmill had a strong 
positive correlation to MMSE scores in our population (RS = 0.874; P = 0.01). Those with higher 
MMSE scores (i.e. less cognitive impairment) were significantly more likely to reach their 
comfortable overground walking speed than individuals with lower scores. 
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Figure 2. Rated Perceived Exertion (RPE) during TW 
Mean reported RPE values on a 0 – 10 scale indicated low perceived exertion. 
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Discussion 
To our knowledge, this is the first study to examine the safety, feasibility, and effects on 
gait of a treadmill-based intervention in individuals with DLB. Key findings of this study suggest 
that a single 20 minute TW intervention is safe and feasible for individuals with DLB, and that 
improvements in gait parameters may be task specific. 
Safety and Feasibility 
Similar to outcomes in the PD population, acceptability of the treadmill intervention was 
good and no adverse events occurred.
28
 Heart rate and blood pressure responses were normal in 
our participants during TW, agreeing with the finding that treadmill training poses relatively low 
cardiovascular risks in individuals with PD.
18
 Combined, these results suggest that our 
intervention was safe for these individuals with DLB. The majority of participants were able to 
complete the full 20 minutes of TW and RPE values indicated low perceived exertion, 
suggesting that this was a tolerable intervention. Aside from the participant who did not 
complete training, only two other participants needed to take rest breaks during the intervention 
and did so for an average of 18 minutes total each. The one participant who could not complete 
the TW had the longest duration of disease and greatest cognitive impairment, possibly 
indicating that this participant was severely deconditioned. 
No participant was able to follow our proposed intervention procedure of starting at their 
comfortable overground walking speed. However, we did have participants who were able to 
increase their treadmill speed as described in our procedures.  The participants who were able to 
reach their comfortable overground walking speed during TW had higher levels of functioning, 
per MMSE scores, than those who did not. After further investigation, we found the variables of 
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MMSE score and ability to reach comfortable overground walking speed during TW to have a 
strong positive correlation. These findings indicate that a single 20 minute session of TW is safe 
and feasible in individuals with DLB, although the standard protocol for treadmill training 
interventions may need to be modified to better accommodate differences in cognitive 
functioning and the orientation to TW.  
Effects on Gait Parameters and Fall Risk (TUG scores) 
We found a single 20 minute session of TW to have significant improvements on gait 
parameters in our participants, specifically in velocity and temporal measures of comfortable 
forward walking. Similar to previous findings in the PD population, participants significantly 
increased their gait speed post-TW.
13,18,28
 Participants also significantly increased their cadence 
and stride velocity and decreased their stance time and double support time, all of which could 
indicate more fluid movement while walking. No participant had markedly worse gait outcomes 
after the TW intervention and the majority of the gait parameters were trending toward 
improvement. Although these improvements are promising, it is unclear whether these results 
were clinically meaningful. The difference in velocity did not meet the threshold to be clinically 
meaningful.
29 
There were no significant differences in spatial parameters of comfortable walking, nor in 
any gait measures of backward and fast walking. It is unclear why we only saw improvements in 
temporal measures of gait, but this finding may be explained by participants increasing their 
cadence rather than stride length to walk faster, which is an adjustment not typically seen in 
other populations.
28
 All significant improvements were seen in comfortable walking, suggesting 
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that TW is task-specific and improvements may be the result of practice. Participants may need 
more training over an extended period of time to see clinically meaningful improvements in gait. 
 There was not a significant difference between pre-test and post-test mean TUG scores 
(25.78 s and 18.87 s; P = 0.282). Our participants’ average times to complete the TUG testing 
could indicate that they are at an increased risk of falls. However, TUG testing has been shown 
to be unreliable for individuals with cognitive impairments and therefore our findings should not 
be taken as conclusive evidence of increased fall risk for the participants in our study.
30
  
The small sample size and inclusion criteria of this study preclude generalization of our 
findings to the entire DLB population. Other limitations of our study include a lack of a 
definitive diagnosis of DLB since this can only be made upon autopsy and a lack of a measure 
for motor disease severity (Unified Parkinson’s Disease Rating Scale). Our study only measured 
immediate effects of TW and therefore it should not be assumed that these improvements were 
retained over a longer period of time.  
 
Conclusion 
In conclusion, our study is the first to demonstrate that TW is a safe and feasible 
intervention in individuals with DLB. Additionally, we found a single 20 minute TW session to 
have favorable effects on gait parameters, suggesting that pace training on a treadmill with 
multiple sessions may be a beneficial intervention for individuals with DLB. Due to our small 
sample size we cannot confirm that the improvements in gait that we found are clinically 
meaningful, but we believe that our results are promising and warrant further investigation. 
Future studies of treadmill training for individuals with DLB should focus on implementing 
treadmill training programs with multiple sessions over extended periods of time, with an 
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emphasis on investigating the long term effects of training that may improve health-related 
quality of life. 
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Appendix A. List of abbreviations 
AD = Alzheimer’s Disease 
DLB = Dementia with Lewy Bodies 
PD = Parkinson’s Disease 
TUG = Timed “Up and Go” 
TW = Treadmill Walking 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
32 
Appendix B. Operational definitions of gait parameters 
 
Gait 
parameter 
Operational definition 
Spatial parameters 
Step length 
(cm) 
Anterior-posterior distance from the heel of one footprint to the heel of the 
opposite footprint 
Stride length 
(cm) 
Anterior-posterior distance between heels of two consecutive footprints of the 
same foot (left to left, right to right); two steps (e.g., a right step followed by a 
left step) comprise one stride or one gait cycle 
Step width (cm) Lateral distance from heel center of one footprint to the line of progression 
formed by two consecutive footprints of the opposite foot 
Temporal parameters 
Cadence 
(steps/min) 
Number of steps per minute, sometimes referred to as step rate 
Step time (s) Time elapsed from initial contact of one foot to initial contact of the opposite 
foot 
Stride time (s) Time elapsed between the initial contacts of two consecutive footfalls of the 
same foot 
Stance time (s) The stance phase is the weight bearing portion of each gait cycle initiated at 
heel contact and ending at toe off of the same foot; stance time is the time 
elapsed between the initial contact and the last contact of a single footfall 
Swing time (s) The swing phase is initiated with toe off and ends with initial contact of the 
same foot; swing time is the time elapsed between the last contact of the 
current footfall to the initial contact of the next footfall of the same foot 
Single support 
time (s) 
Single support occurs when only one foot is in contact with the ground; single 
support time is the time elapsed between the last contact of the opposite 
footfall to the initial contact of the next footfall of the same foot 
Double support 
time (s) 
Double support occurs when both feet are in contact with the ground 
simultaneously; double support time is the sum of the time elapsed during two 
periods of double support in the gait cycle 
Temporophasic parameters 
Stance time 
(%GC) 
Stance time normalized to stride time 
Swing time 
(%GC) 
Swing time normalized to stride time 
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Gait 
parameter 
Operational definition 
Single support 
time (%GC) 
Single support time normalized to stride time 
Double support 
time (%GC) 
Double support time normalized to stride time 
Spatiotemporal parameters 
Gait speed 
(cm/s) 
Calculated by dividing the distance walked by the ambulation time 
Stride speed 
(cm/s) 
Calculated by dividing stride length by the stride time 
cm = centimeters; s = seconds; %GC = % gait cycle. 
Courtesy of: Hollman J, McDade E, Petersen R. Normative spatiotemporal gait parameters in 
older adults. Gait & Posture. May 2011; 34(1): 111-118. doi:10.1016/j.gaitpost.2011.03.024 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
34 
Appendix C. Diagram of normal gait cycle 
 
 
 
 
Courtesy of: Lim M, Huang R, Wu A, Girardi F, Cammisa F. Evaluation of the elderly patient 
with an abnormal gait. The Journal Of The American Academy Of Orthopaedic Surgeons. 
February 2007;15(2):107-117. 
 
 
